Simultaneous inhibition of pan-phosphatidylinositol-3-kinases and MEK as a potential therapeutic strategy in peripheral T-cell lymphomas.
about
MiR-92a mediates AZD6244 induced apoptosis and G1-phase arrest of lymphoma cells by targeting BimClinical development of phosphatidylinositol 3-kinase inhibitors for non-Hodgkin lymphomaPIM kinases as potential therapeutic targets in a subset of peripheral T cell lymphoma cases.Pharmacological targeting of the PI3K/mTOR pathway alters the release of angioregulatory mediators both from primary human acute myeloid leukemia cells and their neighboring stromal cellsOvercoming IGF1R/IR resistance through inhibition of MEK signaling in colorectal cancer models.A three-signal model of T-cell lymphoma pathogenesismiR-137 effects on gastric carcinogenesis are mediated by targeting Cox-2-activated PI3K/AKT signaling pathway.MiR-125b inhibits cell biological progression of Ewing's sarcoma by suppressing the PI3K/Akt signalling pathway.Inhibitory Kinetics and Mechanism of Flavonoids Extracted from Cotinus coggygria Scop. Against Glioblastoma Cancer.Combination of the MEK inhibitor pimasertib with BTK or PI3K-delta inhibitors is active in preclinical models of aggressive lymphomas.EphB and Ephrin-B interactions mediate human mesenchymal stem cell suppression of activated T-cells.Co-targeting aurora kinase with PD-L1 and PI3K abrogates immune checkpoint mediated proliferation in peripheral T-cell lymphoma: a novel therapeutic strategy.Pilot study of sorafenib in relapsed or refractory peripheral and cutaneous T-cell lymphoma.
P2860
Q28118859-6B4A0899-4B4E-43AC-9C98-1780022EB072Q34255861-C10097D1-0F4F-4668-B2E6-A93E4CCA9D65Q34489388-B758DCF2-8F49-4F7E-8D84-D911130E300EQ37132224-844C5979-864C-4E8B-91EC-D9F48360491AQ37349748-3C56A15C-1287-4BDC-8C7B-CBD45E62941BQ38593164-5B5B68B4-90C6-4B0A-AD4F-3C71F7DACA2BQ38971368-54648A59-9538-424D-BEC1-A1700004B3D7Q39024985-BF5AB2F3-0272-4BF0-9636-5C4253845728Q39347456-0D469F65-CF43-4C3C-A250-F5CCDA28C943Q39933783-DC2740F0-0B5A-4980-A96A-39557FCC8F2CQ42962199-0F2FF963-BB21-496C-9A21-82F17053260FQ47147843-9DB4BAAC-3D59-4663-93C6-E773E142DFFDQ54348243-6F5A085B-6079-4071-B766-0BD256694153
P2860
Simultaneous inhibition of pan-phosphatidylinositol-3-kinases and MEK as a potential therapeutic strategy in peripheral T-cell lymphomas.
description
2012 nî lūn-bûn
@nan
2012年の論文
@ja
2012年学术文章
@wuu
2012年学术文章
@zh-cn
2012年学术文章
@zh-hans
2012年学术文章
@zh-my
2012年学术文章
@zh-sg
2012年學術文章
@yue
2012年學術文章
@zh
2012年學術文章
@zh-hant
name
Simultaneous inhibition of pan ...... n peripheral T-cell lymphomas.
@ast
Simultaneous inhibition of pan ...... n peripheral T-cell lymphomas.
@en
type
label
Simultaneous inhibition of pan ...... n peripheral T-cell lymphomas.
@ast
Simultaneous inhibition of pan ...... n peripheral T-cell lymphomas.
@en
prefLabel
Simultaneous inhibition of pan ...... n peripheral T-cell lymphomas.
@ast
Simultaneous inhibition of pan ...... n peripheral T-cell lymphomas.
@en
P2093
P2860
P50
P1433
P1476
Simultaneous inhibition of pan ...... in peripheral T-cell lymphomas
@en
P2093
Beatriz Domínguez-González
Diana Romero
F Javier Alves
Fernando González-Palacios
Guido Kurz
James R Bischoff
Javier Menárguez
Juan F García
Lina Odqvist
Luis Lombardía
P2860
P356
10.3324/HAEMATOL.2012.068510
P50
P577
2012-07-16T00:00:00Z